about
Complement-endothelial cell interactions: pathophysiological implications.Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouseIntracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes.Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humansEndothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs.Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X.Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase.Leptospira icterohemorrhagiae and leptospire peptidolgycans induce endothelial cell adhesiveness for polymorphonuclear leukocytes.Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes.Interaction between chronically HIV-infected promonocytic cells and human umbilical vein endothelial cells: role of proinflammatory cytokines and chemokines in viral expression modulation.The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity.Postmeal portal flow variations in HCV-related chronic hepatitis and liver cirrhosis with and without hyperdynamic syndrome.Hemodynamic effects of a prostacyclin analog (iloprost) on portal flow velocity and volume and visceral artery circulation in patients with lower limb arteriopathy.Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction.Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications.Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation.Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.CD11/CD18-independent neutrophil adherence to inducible endothelial-leucocyte adhesion molecules (E-LAM) in vitro.Iloprost: an adjunctive approach to chronic viral hepatitis treatment.Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients.Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction.Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role?High-risk clinical features predict increased post-infarction myocardial apoptosis and the benefits as a result of an open infarct-related artery.Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivoWidespread Myocardial Inflammation and Infarct-Related Artery PatencyIncreased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failureApoptosis and Post-infarction Left Ventricular RemodelingPhorbol ester causes down-regulation of CD11/CD18-independent neutrophil adherence to endothelium[Mediastinal lymphangioma (with a report on 3 personal cases)]Inhibition of neutrophil adherence to vascular endothelial cells by a new acylated flavonoidMetabolic properties of freshly isolated bovine endothelial cellsIsolation of metabolically active endothelial cells in high yield from bovine cavernous bodies. A model for functional studies on freshly isolated microvascular endothelial cellsBiological activity of a peptidoglycan extracted from Leptospira interrogans: in vitro studiesInterleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery diseaseComplement-endothelial cell interactions: pathophysiological implicationsInflammatory markers and coronary interventions: a potentially useful follow-up modality after stentingPrognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary interventionAtherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial diseasePlasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunctionSoluble interleukin-2 receptor: is there a role in ischaemic cardiomyopathy?
P50
Q33686076-77279A1A-6649-4BB6-A252-C15EF398B3D5Q34091132-BD057A96-FE23-48CE-9CA2-CA9CACA3B694Q34544863-14279E47-39CB-4FA0-B799-D10F4D3CC04DQ35587024-A3D23057-99C3-407E-8D0B-EBA189A0C6F8Q36026145-20D66105-2249-42CB-AF71-25988EC2C9F1Q37866897-0223871D-E045-4144-A737-10A45A3CC80EQ38527744-D888836C-3BA0-4C4E-B9C1-3A760A846286Q39822651-35D35215-F931-44C5-9DE8-EF96063F0EDEQ39901137-090CCA20-6646-48D5-A5FB-CAC2DD79AA16Q40887953-56F6916B-E4A8-4E6E-98EE-E2C839A0A8FAQ41923727-0EAAE209-8FF2-4A18-BA78-9A17F45C8F51Q42980895-1A4039F0-7997-4F0B-81BA-C958C712BC17Q44378480-28D66093-D789-41CB-AE78-74F57806E7DEQ44722295-1F5FF881-16E2-4CAB-B792-9993F7B4B0CBQ44903159-A77A4275-18DA-4C31-B734-310F1B8121D7Q44931537-77ED7E80-5621-42D2-A690-61B89CD0E335Q44938264-CC34C37C-AB27-40DA-B060-90991FD4DC61Q45132958-F65966FC-ECCF-4BDE-8C75-82AD582A7BD7Q45144166-FE53FCF5-B1E9-44C8-9912-0CA55B457599Q45880591-C0340FF9-4F4D-4216-8CE5-E9B201AA9F9EQ46470171-5FA256FD-A3DE-47CB-A257-40ED8128EB10Q51921139-EFB96B52-9895-44B8-82F2-7134D17074FAQ53858753-1C5C60A3-DE03-47F6-BD59-3275F75616DDQ56943166-5F2C509F-60E9-4586-9A65-3AABEDF4FE09Q58230268-FB326FDB-BB9B-487B-A11E-0F3081D5586EQ58314378-8369F66D-27B8-4196-8B0A-AE1E493B630BQ62661736-6E02BAFE-AAE5-41BD-9DA4-EDBA2F0B33C8Q68084474-C7242E98-9475-451F-8535-5ED675DBFE17Q68281106-D34EABDF-0EFA-4221-BA5F-A29323D0C6A8Q69461266-A79128B6-C3FF-47A3-A078-711A164618ABQ71679583-DA7EF350-80C9-42AE-A6E3-43A5D82FB5A8Q71821900-ED221814-1BA7-4C9B-A1DF-A9EE278C0598Q72288833-2BF6BA48-89B8-4DB8-B569-5ECF58A4A986Q73316912-9D414969-675C-4EB7-A5F8-E9F54EEC008FQ73713326-5555F885-91FE-47E0-AEED-CA72EEFB151BQ74450038-12FCDCF8-801C-4898-A6D4-7AEE3079B5C4Q77616409-10AE7311-9F0A-4F40-981E-CDDAAFBCC79AQ78067718-F799E035-6BB9-4D17-8158-E6BC30945C9DQ78860323-450E1380-53BC-4F43-A990-6514DE356A36Q79322057-5D108F4E-C252-4BDB-AF0B-36AA2D2526DC
P50
description
forsker
@nb
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
A. Dobrina
@ast
A. Dobrina
@nl
Aldo Dobrina
@en
Aldo Dobrina
@es
Aldo Dobrina
@nb
type
label
A. Dobrina
@ast
A. Dobrina
@nl
Aldo Dobrina
@en
Aldo Dobrina
@es
Aldo Dobrina
@nb
altLabel
A. Dobrina
@en
prefLabel
A. Dobrina
@ast
A. Dobrina
@nl
Aldo Dobrina
@en
Aldo Dobrina
@es
Aldo Dobrina
@nb
P106
P31
P496
0000-0002-8393-1796